GHRH analogue + selective GHRP · secretagogue pairing
CJC-1295 + Ipamorelin, in research terms
CJC-1295 and Ipamorelin are the most-studied secretagogue pairing on the growth-hormone axis. They are combined because they act through two different receptors — a GHRH analogue and a selective GH-releasing peptide — rather than duplicating one mechanism.
two mechanisms, one pen
CJC-1295 is a GHRH analogue — it mimics growth-hormone-releasing hormone to prompt GH release. Ipamorelin is a selective GH-releasing peptide (a ghrelin-receptor agonist) that amplifies release through a separate receptor. Pairing them lets researchers study both arms of secretagogue signalling together. Both sit in the growth & recovery range.
why ipamorelin is described as 'selective'
Among GH-releasing peptides, ipamorelin is the one studied for a selective profile — it is associated in the literature with GH release without the broader hormonal cross-talk seen with older GHRPs. That selectivity is why it is the GHRP of choice in this combination.
how it relates to the single secretagogues
Tesamorelin isolates the GHRH-analogue arm on its own. This pen adds the GHRP arm on top. Both are the secretagogue alternative to supplying recombinant GH directly — see somatropin.
verifying identity and purity
Because this is a two-compound pen, the certificate of analysis matters for the identity and proportion of each component, not just the total. Every pen ships with an independent, batch-specific COA — see how to read a COA.
research use only
This compound is supplied strictly for in-vitro and laboratory research use only. It is not a medicine, is not for human or veterinary consumption, and nothing on this page is dosing, medical or treatment guidance. Any effect described is stated in the context of published research, not a claim about use.
where to find CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin is supplied in the following research pens — pre-filled, batch-numbered and independently assayed. Save one to your list and we'll email you the moment it's available in your country.
